How soon the side effects of Tirelizumab appear is determined by the patient’s sensitivity and tolerance to the drug and his or her own physical condition, usually ranging from one to several days.
Tirelizumab is mainly used for the treatment of relapsed or refractory classical Hodgkin’s lymphoma treated with at least second-line systemic chemotherapy.
Adverse reactions include fever, hypothyroidism, weight gain, pruritus, decreased white blood cell count, elevated alanine aminotransferase, rash cough, fatigue, elevated blood bilirubin, lung inflammation, severe skin reactions, hypertension, anemia, and infusion reactions.
It is contraindicated in patients with allergic reactions to the active ingredient or any excipients.
How soon the side effects of Tirelizumab appear is determined by the patient’s sensitivity and tolerance to this drug and his or her own physical condition; some people may experience adverse reactions very quickly, others may experience them after a few days, and so on.
The use of this drug should be under the guidance of a doctor. In case of discomfort, seek medical advice promptly.